Dermaliq Therapeutics Announces Positive Topline Results from Phase 1b/2a Trial Evaluating the Safety and Efficacy of DLQ01 for the Treatment of Androgenetic Alopecia (AGA) in Men
DLQ01 is potentially the first new topical treatment option for both men and women suffering from AGA in a very long time.
July 17, 2024
by Biotech Newswire
Dermatology biotech Dermata Therapeutics sets terms for $15 million IPO
Dermata Therapeutics plans to raise $15 million in its initial public offering of 1.9 million shares at a price range of $7 to $9, Renaissance Capital reported.
July 5, 2021
by firstwordpharma
Organon launches as Women’s Health company
Organon is a new company focused on women’s health. In India, Organon will be operating in women’s healthcare, fertility, dermatology, respiratory and bone health products in their portfolio.
June 4, 2021
by expresspharma
Lincoln Pharmaceuticals receives EU GMP approval
The company looks to enter the EU markets very soon with its dermatology, gastro and pain management products and gradually expand product portfolio.
May 20, 2020
by expresspharma
Galderma Launches Online Support to Empower and Equip Rosacea Sufferers to Discuss the True Burden of Their Disease With a Dermatologist
Launched Galderma's new Face up to rosacea campaign aims to help close the communication gap between people with rosacea and dermatologists.
October 23, 2019
by En-CPhI.CN
LEO Pharma completes the acquisition of Bayer’s prescription dermatology business
LEO Pharma completes the acquisition of Bayer’s prescription dermatology business.
July 3, 2019
by worldpharmanews
FDA dermatology advisors found to accept payments after drug approvals
A study has shown that the majority of dermatology advisors to the FDA took payments subsequent to drug approvals.
June 14, 2019
by europeanpharmaceuticalreview
Glenmark forays into branded dermatology segment in US
The branded portfolio for the US market will be developed and commercialised by Glenmark Therapeutics USA
December 20, 2018
by expressbpd
LEO Pharma teams up with Wearifi for dermatology research wearable
LEO Pharma is developing a wearable device based on miniature sensors and plans to assess its clinical potential in dermatology drug development.
December 19, 2018
by pharmaphorum
Almirall and X-Chem Announce Dermatology-Focused Drug Discovery Collaboration
X-Chem, Inc., a privately held biotechnology company applying its innovative drug discovery platform to the generation of novel small molecule therapeutics....
December 13, 2018
by pharmafocusasia
Realm surrenders after back-to-back clinical defeats
Faced with a pair of phase 2 failures, Realm Therapeutics has abandoned the platform that underlies all its drug development programs and engaged advisers to look into a possible sale...
September 18, 2018
by fiercebiotech
Aurobindo to acquire dermatology and oral solids businesses from Sandoz
The acquisition is in line with Aurobindo’s strategy to grow and diversify our business in the US
September 7, 2018
by financialexpress